Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 4.89% vs 31.44% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 21.32% vs 58.01% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -97.77% vs 273.96% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 20.11% vs 54.64% in Mar 2024
Compare Profit and Loss Results of Influx Health.
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
104.00
370.00
-266.00
-71.89%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
104.00
370.00
-266.00
-71.89%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-6.00
6.00
100.00%
Raw Materials Consumed
63.00
170.00
-107.00
-62.94%
Power & Fuel Cost
1.00
18.00
-17.00
-94.44%
Employee Cost
8.00
60.00
-52.00
-86.67%
Operating Expenses
7.00
38.00
-31.00
-81.58%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
24.00
-23.00
-95.83%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
5.00
-5.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
84.00
340.00
-256.00
-75.29%
Operating Profit (PBDIT) excl Other Income
20.00
29.00
-9.00
-31.03%
Other Income
0.00
11.00
-11.00
-100.00%
Operating Profit (PBDIT)
20.00
40.00
-20.00
-50.00%
Interest
0.00
13.00
-13.00
-100.00%
Profit before Depriciation and Tax
20.00
27.00
-7.00
-25.93%
Depreciation
2.00
19.00
-17.00
-89.47%
Profit Before Taxation & Exceptional Items
17.00
8.00
9.00
112.50%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
17.00
8.00
9.00
112.50%
Provision for Tax
4.00
2.00
2.00
100.00%
Profit After Tax
13.00
5.00
8.00
160.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
16.00
163.00
-147.00
-90.18%
Profit Available for appropriations
29.00
169.00
-140.00
-82.84%
Appropriations
29.00
169.00
-140.00
-82.84%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
7.36
1.22
6.14
503.28%
Profit And Loss - Net Sales
Net Sales 104.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.89% vs 31.44% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.32% vs 58.01% in Mar 2024
Profit And Loss - Interest
Interest 0.01 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -97.77% vs 273.96% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 13.37 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.11% vs 54.64% in Mar 2024






